Article
Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancer
1 Apr 2021
Abstract excerpt
BACKGROUND: Tumor mutational burden (TMB) is widely regarded as a predictor of response to immunotherapy. Few researchers have focused on the activity and prognosis of TMB in endometrial cancer (EC) and immune cells. Our study aimed to identify the prognostic role of TMB in EC. METHODS: We downloaded transcriptome data from The Cancer Genome Atlas (TCGA) database. Kaplan-Meier analysis with log-rank test was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
